Literature DB >> 16849535

SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.

Tsuyoshi Saito1, Makoto Nagai, Marc Ladanyi.   

Abstract

Synovial sarcoma is a primitive mesenchymal neoplasm characterized in almost all cases by a t(X;18) fusing the SYT transcriptional coactivator gene with either SSX1 or SSX2, with the resulting fusion gene encoding an aberrant transcriptional regulator. A subset of synovial sarcoma, predominantly cases with the SYT-SSX1 fusion, shows foci of morphologic epithelial differentiation in the form of nests of glandular epithelium. The striking spontaneous mesenchymal to epithelial differentiation in this cancer is reminiscent of a developmental switch, but the only clue to its mechanistic basis has been the observation that most cases of synovial sarcoma with glandular epithelial differentiation (GED) contain SYT-SSX1 instead of SYT-SSX2. We report here that SYT-SSX1 and SYT-SSX2 interact preferentially with Snail or Slug, respectively, and prevent these transcriptional repressors from binding to the proximal E-cadherin promoter as shown by coimmunoprecipitation and chromatin immunoprecipitation. Luciferase reporter assays reveal that SYT-SSX1 and SYT-SSX2 can respectively overcome the Snail- or Slug-mediated repression of E-cadherin transcription. This provides a mechanism by which E-cadherin expression, a prerequisite of epithelial differentiation, is aberrantly derepressed in synovial sarcoma and may also explain the association of GED with the SYT-SSX1 fusion because it interferes with Snail, the stronger repressor of the E-cadherin promoter. Thus, our data provide a mechanistic basis for the observed heterogeneity in the acquisition of epithelial characteristics in synovial sarcoma and highlight the potential role of differential interactions with Snail or Slug in modulating this phenotypic transition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849535     DOI: 10.1158/0008-5472.CAN-05-3697

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma.

Authors:  Alan L Ho; Shyamprasad Deraje Vasudeva; Marick Laé; Tsuyoshi Saito; Violetta Barbashina; Cristina R Antonescu; Marc Ladanyi; Gary K Schwartz
Journal:  Cancer Res       Date:  2012-07-10       Impact factor: 12.701

2.  Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug.

Authors:  Jilong Yang; James A Eddy; Yuan Pan; Andrea Hategan; Ioan Tabus; Yingmei Wang; David Cogdell; Nathan D Price; Raphael E Pollock; Alexander J F Lazar; Kelly K Hunt; Jonathan C Trent; Wei Zhang
Journal:  Mol Cell Proteomics       Date:  2010-07-22       Impact factor: 5.911

3.  The oncomir face of microRNA-206: A permanent miR-206 transfection study.

Authors:  Dóra Mihály; Gergő Papp; Zsolt Mervai; Andrea Reszegi; Péter Tátrai; Gábor Szalóki; Johanna Sápi; Zoltán Sápi
Journal:  Exp Biol Med (Maywood)       Date:  2018-08-15

4.  Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.

Authors:  Lincoln A Edwards; Kevin Woolard; Myung Jin Son; Aiguo Li; Jeongwu Lee; Chibawanye Ene; Samuel A Mantey; Dragan Maric; Hua Song; Galina Belova; Robert T Jensen; Wei Zhang; Howard A Fine
Journal:  J Natl Cancer Inst       Date:  2011-07-19       Impact factor: 13.506

Review 5.  Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.

Authors:  Torsten O Nielsen; Neal M Poulin; Marc Ladanyi
Journal:  Cancer Discov       Date:  2015-01-22       Impact factor: 39.397

Review 6.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

7.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

8.  The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Authors:  Yan Qi; Cui-Cui Wang; Yong-Lai He; Hong Zou; Chun-Xia Liu; Li-Juan Pang; Jian-Ming Hu; Jin-Fang Jiang; Wen-Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

9.  E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells.

Authors:  Helen L Spencer; Angela M Eastham; Catherine L R Merry; Thomas D Southgate; Flor Perez-Campo; Francesca Soncin; Sarah Ritson; Rolf Kemler; Peter L Stern; Christopher M Ward
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

Review 10.  The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.

Authors:  Tsuyoshi Saito
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.